US Expansion Capitalize on US market growth by pursuing partnerships with leading cancer centers and potential joint ventures, building on plans for a precision oncology hub in New York and existing collaborations with major institutions.

Clinical Workflows Position SOPHiA DDM as the core platform to modernize genomic testing workflows within health systems and labs, emphasizing seamless LIS/EMR integration and regulatory compliance to simplify procurement and accelerate adoption.

Liquid Biopsy Potential Leverage the Synnovis collaboration to expand blood-based cancer testing offerings across Europe and beyond, targeting biomarker-driven diagnostics and pharma-sponsored trials.

Biopharma Partnerships Target biopharma and research organizations for co-development of AI-driven diagnostics, companion diagnostics, and precision medicine programs that leverage the platform’s community-driven intelligence.

Training Adoption Offer structured onboarding, training, and certification via the Litmos LMS to drive user proficiency, customer success, and sustained value realization across clinical and research customers.